Quarterly report · Q2
6951.TEDINET S100O9I5
Period2021-04-01 → 2021-09-30
Filed2022-06-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100MQ4F.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥110.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.4bn | 2020-04-01 → 2020-09-30 | Cons. | Net sales |
| Operating income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Operating income | ¥2.5bn | 2020-04-01 → 2020-09-30 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.5bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.8bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.9bn | 2020-04-01 → 2020-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2020-04-01 → 2020-09-30 | Cons. | Profit loss |
| Total assets | ¥168.3bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥146.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥136.7bn | at 2020-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.9bn | at 2021-09-30 | Cons. | Liabilities |
| Total liabilities | ¥95.4bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥77.4bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥46.9bn | at 2020-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.9bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2020-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥662m | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥438m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥11.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2020-04-01 → 2020-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥75.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.59 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.51 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40 | 2020-04-01 → 2020-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.6 | 2020-07-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.3% | at 2020-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥820m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥670m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2020-09-30 | −¥2.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥12.0bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2020-04-01 → 2020-09-30 | ¥737m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2020-04-01 → 2020-09-30 | ¥30.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2020-04-01 → 2020-09-30 | −¥288m |
| —segment total | revenue | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | revenue external | 2020-04-01 → 2020-09-30 | ¥49.4bn |
| —segment total | segment profit | 2020-04-01 → 2020-09-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities and net assets | Prior1YearInstant | 146388000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 168348000000 | JPY |
| Net sales | Prior1YTDDuration | 49388000000 | JPY |
| Net sales | CurrentYTDDuration | 53368000000 | JPY |
| Cost of sales | Prior1YTDDuration | 29170000000 | JPY |
| Cost of sales | CurrentYTDDuration | 30540000000 | JPY |
| Gross profit | Prior1YTDDuration | 20217000000 | JPY |
| Gross profit | CurrentYTDDuration | 22828000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 3931000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 4126000000 | JPY |
| Other sga | Prior1YTDDuration | 13816000000 | JPY |
| Other sga | CurrentYTDDuration | 15025000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 17748000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 19151000000 | JPY |
| Operating income | Prior1YTDDuration | 2468000000 | JPY |
| Operating income | CurrentYTDDuration | 3676000000 | JPY |
| Interest income noi | Prior1YTDDuration | 20000000 | JPY |
| Interest income noi | CurrentYTDDuration | 12000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 67000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 90000000 | JPY |
| Revenue from acceptance of development services noi | Prior1YTDDuration | 27000000 | JPY |
| Revenue from acceptance of development services noi | CurrentYTDDuration | 24000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 113000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | － | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 162000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 270000000 | JPY |
| Subsidy income noi | Prior1YTDDuration | － | JPY |
| Subsidy income noi | CurrentYTDDuration | 712000000 | JPY |
| Other noi | Prior1YTDDuration | 186000000 | JPY |
| Other noi | CurrentYTDDuration | 129000000 | JPY |
| Non operating income | Prior1YTDDuration | 578000000 | JPY |
| Non operating income | CurrentYTDDuration | 1239000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 81000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 81000000 | JPY |
| Loss on sales of accounts receivable noe | Prior1YTDDuration | 3000000 | JPY |
| Loss on sales of accounts receivable noe | CurrentYTDDuration | 3000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | － | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 20000000 | JPY |
| Other noe | Prior1YTDDuration | 91000000 | JPY |
| Other noe | CurrentYTDDuration | 61000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 176000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 167000000 | JPY |
| Ordinary income | Prior1YTDDuration | 2870000000 | JPY |
| Ordinary income | CurrentYTDDuration | 4749000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 55000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 21000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 55000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 21000000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 1000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |